We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.20 | 2.00 | 2.40 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMODX
RNS Number : 8614M
Omega Diagnostics Group PLC
02 May 2018
Omega Diagnostics Group PLC
("Omega" or "the Company" or the "Group")
Closure of Omega Diagnostics GmbH
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces the closure of Omega Diagnostics GmbH ("Omega GmbH").
Further to the announcement on 10 April 2018, the Board has not been able to conclude any transaction for a sale of Omega GmbH. The Board has therefore decided to initiate insolvency proceedings through the German court system, as soon as practically possible, under the guidance of its legal advisers. The contingent cost associated with this closure is not expected to be more than GBP0.45m and could be significantly less than this figure.
For the year ended 31 March 2018, Omega GmbH had sales of approximately EUR3.2 million* and incurred an EBITDA loss of approximately EUR0.4 million*.
The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.
* Figures for the year ended 31 March 2018 are unaudited as at the date of this release.
Contacts:
Hot Features
Premium
Omega Diagnostics Group Tel: 01259 763 030
PLC
Colin King, Chief Executive www.omegadiagnostics.com
Kieron Harbinson, Group
Finance Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/James Thompson
(Corporate Finance)
Camille Gochez/ Abigail
Wayne (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or
omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSSUSMEFASEDI
(END) Dow Jones Newswires
May 02, 2018 02:41 ET (06:41 GMT)
1 Year Omega Diagnostics Chart |
1 Month Omega Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
